Building capacity for systems biology analysis of adverse events following COVID-19 vaccination in low- and middle-income countries

建设低收入和中等收入国家对 COVID-19 疫苗接种后不良事件进行系统生物学分析的能力

• 批准号: 450298
• 负责人: Top Karina A
• 金额: $ 14.55万
• 依托单位: Dalhousie University (Nova Scotia)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-07-01 至 2023-07-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=450298&lang=en
• 关键词: Covid-19; Immunization; Vaccination; Vaccine Safety

The development of safe and effective vaccines is helping to control COVID-19. Though benefits of vaccination outweigh risks, rare, serious adverse events have been reported after vaccine introduction in North America and Europe. One example is thrombosis

开发安全有效的疫苗有助于控制 COVID-19。尽管疫苗接种的好处大于风险，但在北美和欧洲引入疫苗后仍报告了罕见的严重不良事件。血栓形成就是一个例子